These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2252526)

  • 1. The influence of high dose intravenous immunoglobulins on immunological and metabolic pattern in newly diagnosed type I diabetic patients.
    Pantŏ F; Giordano C; Amato MP; Pugliese A; Donatelli M; D'Acquisto G; Galluzzo A
    J Autoimmun; 1990 Oct; 3(5):587-92. PubMed ID: 2252526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus.
    Giordano C; Pantŏ F; Amato MP; Sapienza N; Pugliese A; Galluzzo A
    J Autoimmun; 1990 Oct; 3(5):611-7. PubMed ID: 2252529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.
    Vidal J; Fernández-Balsells M; Sesmilo G; Aguilera E; Casamitjana R; Gomis R; Conget I
    Diabetes Care; 2000 Mar; 23(3):360-4. PubMed ID: 10868866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
    Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
    J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin autoantibodies: evidence of autoimmune disease among a group of Puerto Rican children with newly diagnosed type 1 diabetes mellitus.
    González de Pijem L; Nieves-Rivera F
    P R Health Sci J; 2001 Jun; 20(2):161-4. PubMed ID: 11561476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.
    Zimmet PZ; Tuomi T; Mackay IR; Rowley MJ; Knowles W; Cohen M; Lang DA
    Diabet Med; 1994 Apr; 11(3):299-303. PubMed ID: 8033530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reacting idiotypes on anti-insulin autoantibodies in autoimmune diseases, identified by monoclonal antibodies.
    Kopchaliiska D; Stamenova M; Manolova V; Kehayov I; Dakovska L; Kyurkchiev S
    Clin Immunol Immunopathol; 1998 May; 87(2):130-8. PubMed ID: 9614927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
    Keymeulen B; Vandemeulebroucke E; Ziegler AG; Mathieu C; Kaufman L; Hale G; Gorus F; Goldman M; Walter M; Candon S; Schandene L; Crenier L; De Block C; Seigneurin JM; De Pauw P; Pierard D; Weets I; Rebello P; Bird P; Berrie E; Frewin M; Waldmann H; Bach JF; Pipeleers D; Chatenoud L
    N Engl J Med; 2005 Jun; 352(25):2598-608. PubMed ID: 15972866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
    Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
    Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
    Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS
    Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus serology and isoelectrofocusing pattern of serum immunoglobulins in cyclosporin or placebo-treated type I diabetics.
    Feutren G; de The G; Bach JF
    J Autoimmun; 1992 Apr; 5(2):161-72. PubMed ID: 1320887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAD treatment and insulin secretion in recent-onset type 1 diabetes.
    Ludvigsson J; Faresjö M; Hjorth M; Axelsson S; Chéramy M; Pihl M; Vaarala O; Forsander G; Ivarsson S; Johansson C; Lindh A; Nilsson NO; Aman J; Ortqvist E; Zerhouni P; Casas R
    N Engl J Med; 2008 Oct; 359(18):1909-20. PubMed ID: 18843118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immuno- and regeneration therapy of recently diagnosed diabetes mellitus type I].
    Huth E
    Klin Padiatr; 1985; 197(2):75-84. PubMed ID: 3157826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of insulin release after passive transfer of immunoglobulin from insulin-dependent diabetic children to mice.
    Svenningsen A; Dyrberg T; Gerling I; Lernmark A; Mackay P; Rabinovitch A
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1301-4. PubMed ID: 6355141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of high-dose immunoglobulin and cyclosporine in newly diagnosed diabetic children].
    Romanello C; Grossi F; Radillo L; Betterle C; Marinoni S; Agosti E; Pocecco M; Boehm P
    Pediatr Med Chir; 1991; 13(4):355-8. PubMed ID: 1754467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
    Li X; Liao L; Yan X; Huang G; Lin J; Lei M; Wang X; Zhou Z
    Diabetes Metab Res Rev; 2009 Jul; 25(5):411-6. PubMed ID: 19488999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation in diabetes mellitus.
    Bergamaschini L; Gardinali M; Poli M; Lorini R; Bosi E; Agostoni A
    J Clin Lab Immunol; 1991 Jul; 35(3):121-7. PubMed ID: 1688167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.